First-in-class cancer therapeutic to stimulate natural killer cells

Article Abstract:

The first ever clinical trial of a therapeutic that binds to natural killer (NK) cell receptors is slated to take place before the end of 2006. Its goal is to harness directly the therapeutic potential of NK cells in the treatment of a wide range of immune-related conditions, including cancers, autoimmune disease and infection.

Author: Sheridan, Corm
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
Cell receptors, Immune system

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Cancer surgery joins the dots

Article Abstract:

The use of quantum dots in performing sentinel lymph node biopsy (SLNB) through optical imaging near-infrared (NIR) fluorescence is presented. It represents not only a pioneering medical application of nanocrystals, but also a step forward in the clinical application of sentinel lymph node biopsy (SLNB) in cancer surgery.

Author: Uren, Roger F.
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
Quantum theory, Quantum mechanics, Lymph node biopsy

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA

Erbitux diagnostic latest adjunct to cancer therapy

Article Abstract:

Chimeric antibody Erbitux, which is manufactured by ImClone, has acquired the United States (US) marketing clearance for treating metastatic colorectal cancer. DakoCytomation has received the approval of The US Food and Drug Administration (FDA) for using with Erbitux.

Author: Mitchell, Peter
Publisher: Nature Publishing Co.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2004
United States, Care and treatment, Colorectal cancer, Drug approval

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Cancer, Cancer treatment
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.